I am concerned about the drug pricing protocols in the Build Back Better Act, and they would have the opposite effect limiting research and hampering innovation, in my view.
Larry Bucshon: “I am concerned about the drug pricing protocols in the Build Back Better Act, and they would have the opposite effect…”
Editor's note · Context
Bucshon criticizes the drug pricing measures in the Build Back Better Act for hindering innovation.
Share
More from Larry Bucshon
It is an honor to be at this podium again. When I reflect on my time in Congress and what this House means, I realize that less than 13,000 people in the history of the country have had the opportunity that I have had and I have today. I…
It is clear that the Biden administration has pushed its authorities past reasonable interpretation during the COVID- 19 pandemic. With everything from eviction moratoriums and student loan forgiveness to vaccine and mask mandates being…
I remind my colleagues that the Democrats control the White House and the Senate. I rise today to discuss once again the Biden administration's foolish rush-to-green agenda over U.S. energy dominance. I support an all-of- the-above energy…
In closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time. The SPEAKER pro tempore. The question is on the motion offered by the gentleman from Indiana (Mr. Bucshon) that the House suspend the rules and…





